Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets

[1]  M. Bateson,et al.  Chronological age, biological age, and individual variation in the stress response in the European starling: a follow-up study , 2018, PeerJ.

[2]  Kit Simpson,et al.  Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. , 2018, Current Alzheimer research.

[3]  C. Hadjichrysanthou,et al.  The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments , 2018, PloS one.

[4]  Christoforos Hadjichrysanthou,et al.  Why do so many clinical trials of therapies for Alzheimer's disease fail? , 2017, The Lancet.

[5]  Sterling C. Johnson,et al.  Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis , 2017, JAMA neurology.

[6]  Dev Mehta,et al.  Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 , 2017, Expert opinion on investigational drugs.

[7]  Sang-Goo Lee,et al.  Using DNA Methylation Profiling to Evaluate Biological Age and Longevity Interventions. , 2017, Cell metabolism.

[8]  Harvard T. H. Chan,et al.  APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts , 2017, PLoS medicine.

[9]  Christopher M J Charlton,et al.  R2MLwiN: A Package to Run MLwiN from within R , 2016 .

[10]  N. Faux,et al.  Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. , 2016, Metallomics : integrated biometal science.

[11]  C. Green,et al.  Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model , 2016, Alzheimer's & Dementia.

[12]  C. Dufouil,et al.  Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.

[13]  C. Jack,et al.  Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study , 2015, The Lancet Neurology.

[14]  D. Belsky,et al.  Quantification of biological aging in young adults , 2015, Proceedings of the National Academy of Sciences.

[15]  M. Albert,et al.  Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. , 2014, Current Alzheimer research.

[16]  Sean D Sullivan,et al.  Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS. , 2012, Current Alzheimer research.

[17]  David J. Lunn,et al.  The BUGS Book: A Practical Introduction to Bayesian Analysis , 2013 .

[18]  Richard J. Kryscio,et al.  Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data , 2012, International journal of Alzheimer's disease.

[19]  Magda Tsolaki,et al.  The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months , 2011, International journal of geriatric psychiatry.

[20]  P. Wolf,et al.  Operationalizing diagnostic criteria for Alzheimer’s disease and other age-related cognitive impairment—Part 2 , 2011, Alzheimer's & Dementia.

[21]  A. Simmons,et al.  MRI Measures of Alzheimer's Disease and the AddNeuroMed Study , 2009, Annals of the New York Academy of Sciences.

[22]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[23]  Joylee Wu,et al.  The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set , 2007, Alzheimer disease and associated disorders.

[24]  Lewis H Kuller,et al.  Incidence and Prevalence of Dementia in the Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[25]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.

[26]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[27]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.